Welcome to Our Medtech Talk Podcast Channel

Too often we define the Medtech sector by the number of dollars raised, IPOs helped or companies sold. But the focus neglects the very foundation of the sector - the People. Join the Medtech Talk Podcast each week to hear from entrepreneurs, investors and executives who spend their days developing the tools that make sick people well and health care more efficient.



Stacey Pugh Combines Bedside Background with Market Experience to Affect Change for Type 2 Diabetes

April 25, 2023

 

With a background as a trauma nurse and experience running clinical research programs, Stacey Pugh brought quite a bit of patient-focused experience with her when she shifted to industry. After several roles in the neurovascular space, now she’s leading the charge at Endogenex, which is using pulsed electric fields to treat Type 2 Diabetes. She and host, Geoff Pardo, talk about a medical officer’s first experience doing sales, the challenges in affecting change management in primary care, funding businesses with SPACs, and more.

 

Stacey Pugh

CEO

Endogenex

Stacey Pugh is a leader in medical technology with 20 years of experience in medical device research, development, and commercialization. Prior to joining the team, Stacey was Chief Commercial Officer at Butterfly Network, leading planning, organization, sales and marketing. She has also held positions as President of Medtronic’s Neurovascular Operating Unit and as Vice President of Global Medical Affairs and Clinical Affairs at Covidien’s Neurovascular Division. Stacey spent her early career in a variety of clinical development roles at Kinetic Concepts and began her career in critical care and trauma nursing, nursing education, and directed the human subject research program for Texas Tech University Health Centers.

Meet Our Host, Geoff Pardo

Geoff has been in medtech for over two decades in both operational and investment roles. He is passionate about the industry potential and sharing stories from the front lines of innovation.